Oscar winner Hilary Swank starring in new film “Ordinary Angels”

Academy Award-winning actress Hilary Swank is set to star in “Ordinary Angels,” the next move from the Erwin brothers. It is scheduled for release on October 13.

The movie will tell the story of Sharon Stevens (Swank), a “fierce but struggling hairdresser in small-town Kentucky who discovers a renewed sense of purpose when she meets Ed Schmitt, a widower working hard to make ends meet for his two daughters,” according to Kingdom Story Co. “With his youngest daughter waiting for a liver transplant, Sharon sets her mind to helping the family and will move mountains to do it. What unfolds is the inspiring tale of faith, everyday miracles and ordinary angels.”

Swank, who is expecting twins, said she was drawn to the story “because it’s such a powerful reminder that angels reside everywhere among us.”

“And that faith, hope, grit and positivity are all powerful fuel for miracles,” she said. “It’s also a story about the power of organ donation, something incredibly near and dear to my heart. I couldn’t be more thrilled to be a part of this story and message.”

The 48-year-old actress won Oscars for her roles in “Boys Don’t Cry” and “Million Dollar Baby.” She also has received two Golden Globes, a Critics’ Choice Award, an Independent Spirit Award, a Gotham Tribute Award and a Screen Actors Guild Award.

“Ordinary Angels” is directed by Jon Gunn, written by Meg Tilly and Kelly Fremon Craig, and produced by Kingdom Story Co., the group behind hits including “I Can Only Imagine” and “Woodlawn.”

“Ordinary Angels” comes on the heels of the success of “Jesus Revolution,” which was released has grossed $45.5 million since its release last month. Based on a true story, the film is set in the 1970s and chronicles the true story of a spiritual awakening among hippies in Southern California.  The film’s Rotten Tomatoes audience score is 98 percent from more than 5,000 reviews, and it has also received an A+ CinemaScore. According to Collider, “Jesus Revolution” is Lionsgate’s highest-grossing post-pandemic film.

–Dwight Widaman | MV